A detailed history of Vontobel Holding Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Vontobel Holding Ltd. holds 17,000 shares of ADPT stock, worth $79,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,000
Previous 13,000 30.77%
Holding current value
$79,730
Previous $47,000 85.11%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$3.37 - $5.12 $13,480 - $20,480
4,000 Added 30.77%
17,000 $87,000
Q2 2024

Aug 13, 2024

BUY
$2.34 - $3.96 $30,419 - $51,480
13,000 New
13,000 $47,000
Q1 2022

May 13, 2022

SELL
$10.12 - $28.9 $454,762 - $1.3 Million
-44,937 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$25.17 - $36.85 $68,965 - $100,969
-2,740 Reduced 5.75%
44,937 $1.27 Million
Q3 2021

Oct 29, 2021

BUY
$30.02 - $39.87 $1.19 Million - $1.58 Million
39,677 Added 495.96%
47,677 $1.62 Million
Q4 2020

Feb 12, 2021

BUY
$45.01 - $65.47 $360,080 - $523,760
8,000 New
8,000 $473,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.